Inflammation plays a key role in the progression of AD, while common inflammatory biomarkers C-reactive protein (CRP) and Interleukin-6 (IL-6) have poor specificity and efficiency [10,11,12]. The gene discussed is CRP; the disease is Alzheimer disease.